With the analysis among 159 patents, we discovered top 28 key players by total patent application. Merck & Co., Inc., Takeda Pharmaceutical Co., Ltd., AbbVie, Inc. are dominant in this area. They take 40.88% of the total patent filing.
New Jersey, United States
Patent: 26
Tokyo-to, Japan
Patent: 20
Illinois, United States
Patent: 19
Noord-Holland, Netherlands
Patent: 10
California, United States
Patent: 9
Genève, Switzerland
Patent: 9
Nagano-ken, Japan
Patent: 8
Jiangsu Sheng, China
Patent: 7
No data, please try another search term
With the analysis among related 67 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing AbbVie, Inc., Myovant Sciences GmbH, Neurocrine Biosciences, Inc. take 58.21% of patent filing during this period.
Illinois, United States
Patent: 19
California, United States
Patent: 9
Genève, Switzerland
Patent: 9
Nagano-ken, Japan
Patent: 7
Guangdong Sheng, China
Patent: 3
Hainan Sheng, China
Patent: 2
Shanghai Shi, China
Patent: 2
Guangdong Sheng, China
Patent: 2
With the analysis among related 67 patents in last 5 years, we discover 11 new entrants. AbbVie, Inc., Myovant Sciences GmbH, Neurocrine Biosciences, Inc. are the most active new entrants in this area.
Illinois, United States
Patent: 19
California, United States
Patent: 9
Genève, Switzerland
Patent: 9
Guangdong Sheng, China
Patent: 3
Hainan Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 2
Andhra Pradesh, India
Patent: 1
Sichuan Sheng, China
Patent: 1
No data, please try another search term